Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
ESOC 2022
AAN 2022
CONy 2022
AD/PD 2022
World Sleep 2022
ACTRIMS 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Xavier Montalban
3:14
Using DMTs beyond patients with active MS
Xavier Montalban
• 29 Mar 2022
1:30
Differential efficacy of DMTs in patients with active and inactive MS
Xavier Montalban
• 29 Mar 2022
0:58
Future areas of improvement in treating MS
Xavier Montalban
• 29 Mar 2022
1:20
Using digital technology to facilitate MS management
Xavier Montalban
• 29 Mar 2022
2:08
The diagnostic and therapeutic landscape of MS in 2021
Xavier Montalban
• 23 Sep 2021
1:08
Neuroregenerative agents in progressive multiple sclerosis
Xavier Montalban
• 23 Sep 2021
2:17
Future directions for progressive multiple sclerosis
Xavier Montalban
• 23 Sep 2021
4:46
Current treatments for primary and secondary progressive multiple sclerosis
Xavier Montalban
• 23 Sep 2021
